The University of Chicago Header Logo

Connection

Allison H. Bartlett to Infliximab

Back to Details
This is a "connection" page, showing publications Allison H. Bartlett has written about Infliximab.
Allison H. Bartlett
Connection Strength
0.194
Infliximab
  1. The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
    View in: PubMed
    Score: 0.165
  2. A 12-week-old male with a 10-day history of fever. Pediatr Ann. 2014 May; 43(5):e111-5.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.